Observations show cannabidiol's anti-inflammatory impact in immunocompromised individuals, suggesting potential for pain management.
Cannabidiol exhibits mixed immunomodulatory effects with pro- and anti-inflammatory signals. Understanding the clinical safety of cannabidiol use is important given the paucity of pain control options available for immunocompromised transplant populations.
No takes yet. Share an insight, caveat, or question.
Gisch et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: